Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Revenue (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Revenue for 2 consecutive years, with $22.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 53.4% to $22.6 million in Q4 2025 year-over-year; TTM through Oct 2025 was $74.3 million, a 107.61% increase, with the full-year FY2025 number at $59.8 million, up 115.05% from a year prior.
  • Revenue was $22.6 million for Q4 2025 at Kestra Medical Technologies, up from $19.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $22.6 million in Q4 2025 to a low of $8.3 million in Q1 2024.